, Advanced Research Director, SORIN CRM within Cardiac Rhythm Management business unit,
 
 
Renzo Dal Molin is the Director of Advanced Research for SORIN CRM, Cardiac Rhythm Management Business Unit of SORIN GROUP. He is responsible for advanced research mainly conducted in national and European projects. His scope is to bring innovation in pacemakers, implantable sensors and defibrillators, active implantable medical devices communication and home monitoring systems.
 
He is Vice Chairman for EPoSS (European Technology Platform on Smart Systems Integration) & co chairman of Working Groups Smart Systems for Healthy Living and Applied Micro-Nano-Bio Systems

He is very active in standardization as he was involved in ECC reports 149 and 150 published by the European Communications Office and rapporteur of ETSI standards EN 301 559 and EN301 489 - 35 EMC for LP-AMI. He has a 32 years’ experience in the biomedical industry. He obtained his masters in Electrical Engineering and Biomedical Engineering in 1979 from ESSTIN and University of Nancy. He then occupied in SORIN CRM different positions like pacemaker or defibrillator project manager, integrated circuits design manager. He holds more than 20 US and European patents and his author of 15 publications.

Sorin CRM is now in third position in Europe and second position in Japan in the treatment of slow cardiac rhythm disorders. SORIN GROUP is a global medical device company and a leader in the treatment of cardiovascular diseases 3,750 employees in the world, World Leader in Cardiopulmonary with a 35% market share, worldwide, #2 Heart Valve Company in Europe, listed on the Milan Stock Exchange